文献速递胃肠外科

单吻合口胃旁路术、Roux-en-Y胃旁路术与袖状胃切除术的中期结局比较:6,234例回顾性队列研究

Comparative midterm ramifications of one anastomosis gastric bypass, Roux-en-Y gastric bypass, and sleeve gastrectomy: A retrospective cohort study of 6,234 patients.
PubMed 文献 · Surgery · 2026-01-31

该回顾性队列研究基于全国代谢减重手术登记处和Maccabi健康服务数据,纳入2016至2019年间接受单吻合口胃旁路术、Roux-en-Y胃旁路术或袖状胃切除术的≥18岁患者。单吻合口胃旁路术3年减重效果最佳(30.9%),但相比袖状胃切除术与更高的肛裂风险和更低的便秘风险相关,且单吻合口胃旁路术和Roux-en-Y胃旁路术均与更高的腹痛、腹泻和胃溃疡风险相关。

要点

  • 单吻合口胃旁路术3年减重效果达30.9%,优于袖状胃切除术。
  • 单吻合口胃旁路术相比袖状胃切除术肛裂风险更高(aOR 1.85),便秘风险更低(aOR 0.62)。
  • 单吻合口胃旁路术和Roux-en-Y胃旁路术均与更高的腹痛、腹泻和胃溃疡风险相关。

核心结论

  • 单吻合口胃旁路术减重效果优于袖状胃切除术,但特定胃肠道并发症发生率更高。
  • 选择最佳代谢减重手术方式时需额外考虑并发症风险,并进行个体化术后监测。

研究设计与样本

  • 回顾性队列研究,使用全国代谢减重手术登记处和Maccabi健康服务数据。
  • 纳入2016至2019年间接受单吻合口胃旁路术、Roux-en-Y胃旁路术或袖状胃切除术的≥18岁患者,共6,234例。
  • 采用多变量逻辑回归和倾向性评分匹配估计调整比值比。

主要发现

  • 单吻合口胃旁路术组2,249例(36.1%),Roux-en-Y胃旁路术组447例(7.2%),袖状胃切除术组3,538例(56.8%)。
  • 术前平均BMI:单吻合口胃旁路术41.3 ± 4.9 kg/m2,Roux-en-Y胃旁路术40.4 ± 4.7 kg/m2,袖状胃切除术41.6 ± 4.9 kg/m2。
  • 单吻合口胃旁路术3年减重效果为30.9%(P < .001)。
  • 与袖状胃切除术相比,单吻合口胃旁路术肛裂调整比值比1.85(95%CI 1.38-2.49),便秘调整比值比0.62(95%CI 0.49-0.79)。
  • 调整混杂因素后,单吻合口胃旁路术和Roux-en-Y胃旁路术均与更高的腹痛、腹泻和胃溃疡风险相关。

临床怎么用

  • 单吻合口胃旁路术可提供更优减重效果,但需警惕肛裂等特定胃肠道并发症。
  • 术后应进行个体化监测,尤其关注腹痛、腹泻和胃溃疡等并发症。
  • 选择术式时需综合权衡减重效果与并发症风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: One-anastomosis gastric bypass is a commonly performed metabolic bariatric surgery, yet comprehensive comparisons of its midterm outcomes with Roux-en-Y gastric bypass and sleeve gastrectomy remain limited. The study aimed to assess midterm outcomes, including weight loss and 3-year post-metabolic bariatric surgery complications, in a nationwide cohort. METHODS: This retrospective cohort study included patients aged ≥18 years who underwent one-anastomosis gastric bypass, Roux-en-Y gastric bypass, or sleeve gastrectomy between 2016 and 2019, using data from the National Metabolic Bariatric Surgery Registry and Maccabi Health Services, the second largest health provider. Adjusted odds ratios for study outcomes were estimated using multivariable logistic regressions and propensity score matching. RESULTS: The study comprised 2,249 one-anastomosis gastric bypass (36.1%), 447 Roux-en-Y gastric bypass (7.2%), and 3,538 sleeve gastrectomy (56.8%) patients. Preoperative mean body mass index values were 41.3 ± 4.9, 40.4 ± 4.7, and 41.6 ± 4.9 kg/m2 for one-anastomosis gastric bypass, Roux-en-Y gastric bypass, and sleeve gastrectomy, respectively. One-anastomosis gastric bypass achieved the greatest weight-loss efficacy of 30.9% at 3 years of follow-up (P < .001). One-anastomosis gastric bypass was associated with higher odds of anal fissure (adjusted odds ratio, 1.85; 95% confidence interval, 1.38-2.49) alongside lower odds of constipation (adjusted odds ratio, 0.62; 95% confidence interval, 0.49-0.79), compared with sleeve gastrectomy. Both one-anastomosis gastric bypass and Roux-en-Y gastric bypass were associated with a higher likelihood of abdominal pain, diarrhea, and stomach ulcers compared with sleeve gastrectomy, after adjustment for potential confounders. CONCLUSION: One-anastomosis gastric bypass demonstrated a greater magnitude of weight loss compared with sleeve gastrectomy but was associated with a higher incidence of specific gastrointestinal complications. These findings suggest additional considerations when selecting the optimal metabolic bariatric surgery approach, alongside tailored postoperative surveillance.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Vinograd A, Keinan Boker L, Dichtiar R, et al. Comparative midterm ramifications of one anastomosis gastric bypass, Roux-en-Y gastric bypass, and sleeve gastrectomy: A retrospective cohort study of 6,234 patients. Surgery. 2026. PMID: 41621274. doi:10.1016/j.surg.2026.110083

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。